Skip to main content
. 2019 Mar 30;9(2):281–297. doi: 10.1007/s13555-019-0291-4

Fig. 2.

Fig. 2

Threshold analysis result for Japanese adults aged ≥ 65 years from payers’ perspective. HZ herpes zoster, PHN postherpetic neuralgia, QALY quality-adjusted life year, RZV recombinant zoster vaccine